These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 10894904

  • 21. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M, Wada H, Wakita Y, Nakase T, Hiyoyama K, Nagaya S, Mori Y, Shiku H.
    Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
    [Abstract] [Full Text] [Related]

  • 22. The role of tissue factor in patients undergoing open repair of ruptured and nonruptured abdominal aortic aneurysms.
    Hobbs SD, Haggart P, Fegan C, Bradbury AW, Adam DJ.
    J Vasc Surg; 2007 Oct; 46(4):682-6. PubMed ID: 17764874
    [Abstract] [Full Text] [Related]

  • 23. Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor.
    Takahashi H, Sato N, Shibata A.
    Thromb Res; 1995 Nov 15; 80(4):339-48. PubMed ID: 8585047
    [Abstract] [Full Text] [Related]

  • 24. Tissue factor, its pathway inhibitor, and metabolic disturbances in long-term peritoneal dialysis.
    Zemanová P, Opatrný K, Opatrná S, Vít L, Sefrna F, Racek J.
    Kidney Blood Press Res; 2003 Nov 15; 26(5-6):368-75. PubMed ID: 14610342
    [Abstract] [Full Text] [Related]

  • 25. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
    Kaikita K, Takeya M, Ogawa H, Suefuji H, Yasue H, Takahashi K.
    J Pathol; 1999 Jun 15; 188(2):180-8. PubMed ID: 10398162
    [Abstract] [Full Text] [Related]

  • 26. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
    Adams MJ, Palatinus AA, Harvey AM, Khalafallah AA.
    Lupus; 2011 Dec 15; 20(14):1474-83. PubMed ID: 21993387
    [Abstract] [Full Text] [Related]

  • 27. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
    Xiong SL, Wang Q, Zheng L, Li JL, Wen ZB, He SL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec 15; 27(12):1821-3. PubMed ID: 18158992
    [Abstract] [Full Text] [Related]

  • 28. [Plasma tissue factor and tissue factor pathway inhibitor levels in acute myocardial infarction patients with no-reflow during percutaneous coronary intervention].
    Xu P, Qi XY, Li CH, Zhang JH, Liu DM, Liu J, Wang WL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov 15; 36(11):1013-5. PubMed ID: 19102916
    [Abstract] [Full Text] [Related]

  • 29. Tissue factor pathway inhibitor (TFPI) levels in the plasma and urine of children with meningococcal disease.
    Eling M, Stephens AC, Oragui EE, Rivers RP, Levin M.
    Thromb Haemost; 2001 Feb 15; 85(2):240-4. PubMed ID: 11246540
    [Abstract] [Full Text] [Related]

  • 30. Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1.
    Ott I, Andrassy M, Zieglgänsberger D, Geith S, Schömig A, Neumann FJ.
    Blood; 2001 Jun 15; 97(12):3721-6. PubMed ID: 11389008
    [Abstract] [Full Text] [Related]

  • 31. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients.
    Teng Y, Jiang R, Lin Q, Ding C, Ye Z.
    Thromb Res; 2010 Jul 15; 126(1):e41-5. PubMed ID: 20226500
    [Abstract] [Full Text] [Related]

  • 32. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction.
    Steppich B, Mattisek C, Sobczyk D, Kastrati A, Schömig A, Ott I.
    Thromb Haemost; 2005 Jan 15; 93(1):35-9. PubMed ID: 15630488
    [Abstract] [Full Text] [Related]

  • 33. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
    Paysant J, Soria C, Cornillet-Lefèbvre P, Nguyen P, Lenormand B, Mishal Z, Vannier JP, Vasse M.
    Br J Haematol; 2005 Nov 15; 131(3):356-65. PubMed ID: 16225656
    [Abstract] [Full Text] [Related]

  • 34. Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus.
    El-Ghoroury EA, El-Din HG, Abdel-Kader M, Ragab S.
    Blood Coagul Fibrinolysis; 2008 Jan 15; 19(1):7-13. PubMed ID: 18180609
    [Abstract] [Full Text] [Related]

  • 35. Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies.
    Farsi A, Domeneghetti MP, Brunelli T, Gori AM, Fedi S, Gensini GF, Giglioli C, Prisco D, Passaleva A, Meroni PL, Del Papa N, Abbate R.
    Atherosclerosis; 2001 Feb 01; 154(2):429-36. PubMed ID: 11166776
    [Abstract] [Full Text] [Related]

  • 36. Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor.
    Godoi LC, Gomes KB, Alpoim PN, Carvalho Md, Lwaleed BA, Sant'Ana Dusse LM.
    J Thromb Thrombolysis; 2012 Jul 01; 34(1):1-6. PubMed ID: 22461171
    [Abstract] [Full Text] [Related]

  • 37. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
    Naumnik B, Borawski J, Chyczewski L, Pawlak K, Mysliwiec M.
    Nephrol Dial Transplant; 2006 Dec 01; 21(12):3450-7. PubMed ID: 16982632
    [Abstract] [Full Text] [Related]

  • 38. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction.
    Soejima H, Ogawa H, Yasue H, Kaikita K, Takazoe K, Nishiyama K, Misumi K, Miyamoto S, Yoshimura M, Kugiyama K, Nakamura S, Tsuji I.
    J Am Coll Cardiol; 1999 Oct 01; 34(4):983-8. PubMed ID: 10520779
    [Abstract] [Full Text] [Related]

  • 39. Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosis.
    Fujii M, Hayakawa H, Urano T, Sato A, Chida K, Nakamura H, Takada A.
    Thromb Res; 2000 Jul 15; 99(2):111-7. PubMed ID: 10946084
    [Abstract] [Full Text] [Related]

  • 40. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S, Zdrojewski Z, Jagodzinski P, Rutkowski B.
    Scand J Urol Nephrol; 2007 Jul 15; 41(3):237-42. PubMed ID: 17469034
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.